Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)
Rethinking Clinical Trials
NOVEMBER 1, 2022
Department of Population Health Sciences. Senior Vice President, Population and Public Health. Director, Vanderbilt Institute for Medicine and Public Health. HERO Registry; HERO TOGETHER; Hydroxychloroquine; COVID-19; PCORI; PCORnet. Over 1300 participants were recruited from the HERO Registry. Key Points.
Let's personalize your content